-
September 6, 2010 - Volume 88, Number 36
- p. 58
Science & Technology Concentrates
J. Am. Chem. Soc.
IMMUNE ATTACK ARM-Ps use PSMA receptors to deliver cytotoxic antibodies to prostate-cancer cells.
More Science & Technology Concentrates
- H2 At The Tip Of STM Boosts Resolution
- STM resolution of complex organic molecules can be greatly enhanced by modifying the tip
- Binding Site Broadens Prospects For Prostate-Cancer Drugs
- Scientists have found a new binding site in prostate-specific membrane antigen, a cancer-cell-surface receptor
- Calculated NMR Approach Improves Isomer Identification
- A probability measure works unusually well in matching calculated and experimental spectra
- Solvation Shell Helps Track Charge Transfer
- Researchers report monitoring ultrafast charge transfer in a dye molecule via the IR spectrum of its solvent shell
- Altruistic Bacteria Thwart Antibiotic
- Highly resistant bacteria produce extra indole to help their less resistant siblings survive a norfloxacin assault
- Nature's Route To Sunscreen Revealed
- Cyanobacteria are found to use a multienzyme pathway to build small molecules for sun protection
- Petal Shapes From A β–Peptide
- A research team has identified a β–peptide that self-assembles to form unprecedented 3-D structures
- Another Target For Alzheimer's Drugs
- A molecular probe fashioned from a cancer drug that inhibits amyloid-β helps uncover γ-secretase activating protein
Topics Covered
In work that could aid the search for prostate cancer treatments, scientists have identified a new binding site in a cell-surface receptor that has become an important target for prostate cancer drugs. Last year, David A. Spiegel of Yale University and coworkers developed a class of small molecules called ARM-Ps (antibody-recruiting molecules targeting prostate cancer) that kill prostate cancer cells by a novel mechanism: They bind to cytotoxic antibodies and deliver them to prostate-specific membrane antigen (PSMA), a receptor on prostate cancer cell surfaces. Now, in a study of ARM-P analogs, Spiegel’s group has found a previously unreported arene-binding site in PSMA that improves binding affinities (J. Am. Chem. Soc., DOI: 10.1021/ja104591m). ARM-P derivatives that hit the new site have affinities as low as 20 pM, among the best reported affinities for PSMA. In addition to the site’s therapeutic implications, Spiegel says he believes its structural simplicity—it is composed of only three amino acids—“suggests the intriguing possibility that such sites are broadly present in the proteome and could serve as useful tools in the optimization of protein-ligand interactions in general.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © 2011 American Chemical Society
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!
Popular Sections
ACS, Analytical SCENE, Business, Careers, Economy, Editor, Education, Employment, Environmental SCENE, Letters, Government, Photo Galleries, Policy, Movies, Multimedia, Nanotechnology, Newscripts, Reel Science, Safety Letters, Science, Stem Cells, Stimulus Funds, Technology, Vaccines, Videos, What's That Stuff
Advertisements
